A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment
Journal of Thrombosis and Haemostasis 22(4): 936-950
Article 2023 English
Authors
CG
Cristina Gallego‐Fabrega
GT
Gerard Temprano‐Sagrera
JC
Jara Cárcel‐Márquez
Abstract
1 min read
Thrombolytic recombinant tissue plasminogen activator (r-tPA) treatment is the only pharmacologic intervention available in the ischemic stroke acute phase. This treatment is associated with an increased risk of intracerebral hemorrhages, known as hemorrhagic transformations (HTs), which worsen the patient's prognosis.
Maurizio Paciaroni, Clotilde Balucani, Giancarlo Agnelli, Valeria Caso, Giorgio Silvestrelli, James C. Grotta, Andrew M. Demchuk, Sung‐Il Sohn, Giovanni Orlandi, Didier Leys, Alessandro Pezzini, Andrei V. Alexandrov, Mauro Silvestrini, Luisa Fofi, Kristian Barlinn, Domenico Inzitari, Carlo Ferrarese, Rossana Tassi, Georgios Tsivgoulis, Domenico Consoli, Antonio Baldi, Paolo Bovi, E. Luda, Giampiero Galletti, Paolo Invernizzi, Maria Luisa DeLodovici, Francesco Corea, Massimo Del Sette, Serena Monaco, Simona Marcheselli, Andrea Alberti, Michele Venti, Monica Acciarresi, Cataldo D’Amore, Federica Macellari, Alessia Lanari, Paolo Previdi, Nicole R. Gonzales, Renganayaki Pandurengan, Farhaan Vahidy, M. Rick Sline, Simerpreet Bal, Alberto Chiti, Gino Gialdini, Frédéric Dumont, Charlotte Cordonnier, Stéphanie Debette, Alessandro Padovani, Raffaella Cerqua, Ulf Bodechtel, Jessica Kepplinger, Mascia Nesi, Patrizia Nencini, Simone Beretta, Claudia Trentini, Giuseppe Martini, Charitomeni Piperidou, Ioannis Heliopoulos, Sebastiano D’Anna, Manuel Cappellari, E Donati, Giorgio Bono, E Traverso, Danilo Toni
Maurizio Paciaroni, Giancarlo Agnelli, Francesco Corea, Walter Ageno, Andrea Alberti, Alessia Lanari, Valeria Caso, Sara Micheli, Luca Bertolani, Michele Venti, Francesco Palmerini, Sergio Biagini, Gıancarlo Comı, Paolo Previdi, Giorgio Silvestrelli
Discussion(0)
No comments yet. Be the first to comment.